Ontario Institute for Cancer Research
Research institute that collaborates with partners across ontario and around the world to accelerate the development of new cancer research discoveries and propel them from the lab to the clinic, bringing health and economic benefits to the people of ontario.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| Total Funding | 000k | ||
Related Content
The Ontario Institute for Cancer Research (OICR) is a leading research organization dedicated to advancing cancer research and developing real-world solutions to improve the lives of those affected by cancer. OICR operates in the life sciences sector, focusing on areas such as genomics, informatics, diagnostic development, drug discovery, immuno-oncology, and imaging. The institute collaborates with top researchers and institutions across Ontario and globally, leveraging a multi-institutional model to drive innovation and translational research. OICR serves a diverse range of clients, including cancer patients, healthcare providers, and biotechnology startups. The organization generates revenue through a combination of public funding, private investments, and partnerships with industry stakeholders. OICR's business model emphasizes collaboration and investment in early-stage biotechnology companies, helping them advance their cancer innovations from concept to market. The institute's investment programs have successfully attracted significant funding to the life sciences sector, with a portfolio of biotechnology startups that have collectively raised $1.5 billion in 2023. This milestone represents a 30-fold leverage from the private sector for FACIT investments, highlighting OICR's impact on the local and global cancer research landscape.
Keywords: cancer research, genomics, informatics, diagnostics, drug discovery, immuno-oncology, imaging, biotechnology, investment, translational research.
